Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

Clinical trial NCT06058234 · RECRUITING

Trial details

NCT number: NCT06058234
Sponsor: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group
Status: RECRUITING
Study type: OBSERVATIONAL

Mild Alzheimer's Disease Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Start date: 2023-07-06
Primary completion: 2028-06-30
Enrollment: 8680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.